Page last updated: 2024-08-23

promegestone and Fibroid

promegestone has been researched along with Fibroid in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (33.33)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bulun, SE; Coon, JS; Kujawa, SA; Liu, S; Okeigwe, I; Yin, P	1
Barker, NM; Caplan, AI; Carrino, DA; Hurd, WW; Liu, JH; Mesiano, S; Tan, H	1
Britten, J; Catherino, WH; Cox, J; Malik, M; Patel, A	1
Berry, E; Bulun, S; Chakravarti, D; Clardy, J; Hardt, J; Hoekstra, AV; Kim, JJ; Lu, Z; Marsh, E; Sefton, EC; Yin, P	1
Bulun, SE; Cheng, YH; Innes, J; Ishikawa, H; Kim, JJ; Lin, Z; Marsh, EE; Reierstad, S; Thung, S; Utsunomiya, H; Xu, E; Xue, Q; Yin, P	1
Andersen, RN; Costlow, ME; ElDeib, MM	1
Andersen, RN; ElDieb, MR	1
Al-Azzawi, F; Thompson, J; Wahab, M	1
Bahary, CM; Beery, R; Geier, A; Gorodeski, IG; Lunenfeld, B; Neri, A	1

Trials

1 trial(s) available for promegestone and Fibroid

Article	Year
The effect of submucous fibroids on the dose-dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy. BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:3 Topics: Dose-Response Relationship, Drug; Endometrium; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Middle Aged; Postmenopause; Progesterone Congeners; Promegestone; Uterine Hemorrhage; Uterine Neoplasms	2000

Article

Year

The effect of submucous fibroids on the dose-dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy.

BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:3

Topics: Dose-Response Relationship, Drug; Endometrium; Female; Hormone Replacement Therapy; Humans; Leiomyoma; Middle Aged; Postmenopause; Progesterone Congeners; Promegestone; Uterine Hemorrhage; Uterine Neoplasms

2000

Other Studies

8 other study(ies) available for promegestone and Fibroid

Article	Year
Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma. Oncogene, 2019, Volume: 38, Issue:15 Topics: Adult; Cell Proliferation; DNA Methylation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Mediator Complex; Middle Aged; Progesterone; Promegestone; RANK Ligand; Receptors, Progesterone; Stem Cells; Transcription Initiation Site; Transcriptional Activation; Uterine Neoplasms	2019
Proteoglycans in Leiomyoma and Normal Myometrium: Abundance, Steroid Hormone Control, and Implications for Pathophysiology. Reproductive sciences (Thousand Oaks, Calif.), 2016, Volume: 23, Issue:3 Topics: Adult; Cell Line, Transformed; Cell Line, Tumor; Decorin; Estradiol; Female; Humans; Leiomyoma; Middle Aged; Myometrium; Progesterone; Promegestone; Proteoglycans; Uterine Neoplasms	2016
Mifepristone inhibits extracellular matrix formation in uterine leiomyoma. Fertility and sterility, 2016, Volume: 105, Issue:4 Topics: Cell Line, Transformed; Dose-Response Relationship, Drug; Extracellular Matrix; Female; Hormone Antagonists; Humans; Leiomyoma; Mifepristone; Promegestone; Tumor Cells, Cultured; Uterine Neoplasms	2016
Progestins activate the AKT pathway in leiomyoma cells and promote survival. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:5 Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Female; Fluorescent Antibody Technique; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Leiomyoma; Mifepristone; Oncogene Protein v-akt; Phosphorylation; Progestins; Promegestone; Signal Transduction; Uterine Neoplasms	2009
Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:11 Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Female; Gene Expression Regulation; Genes, bcl-2; Humans; Leiomyoma; Luciferases; Progesterone; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Uterine Neoplasms	2007
Ligand-induced change in sedimentation behavior of human progestin receptors. Steroids, 1983, Volume: 42, Issue:6 Topics: Centrifugation, Density Gradient; Chemical Phenomena; Chemistry; Cytosol; Durapatite; Endometrium; Female; Humans; Hydroxyapatites; Leiomyoma; Ligands; Myometrium; Promegestone; Protamines; Receptors, Progesterone; Uterine Neoplasms	1983
The effect of leupeptin on progestin receptors of human uterine tissues. The Journal of clinical endocrinology and metabolism, 1982, Volume: 55, Issue:5 Topics: Centrifugation, Density Gradient; Drug Stability; Endometrium; Female; Humans; Leiomyoma; Leupeptins; Myometrium; Oligopeptides; Promegestone; Receptors, Progesterone; Specimen Handling; Uterine Neoplasms; Uterus	1982
Characterization of the nuclear progesterone receptor in human uterine leiomyoma. European journal of obstetrics, gynecology, and reproductive biology, 1986, Volume: 23, Issue:1-2 Topics: Cell Nucleus; Cytosol; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Kinetics; Leiomyoma; Middle Aged; Progesterone; Promegestone; Receptors, Progesterone; Uterine Neoplasms	1986